Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BYDiagnostics (Basel, Switzerland)

Serum Free Fatty Acid-Based Diagnostic Index for Cervical Cancer Including High-Risk HPV-Negative Cases: An Independent Validation Study

  • Yuki Katoh1
  • Yosuke Fujii1
  • Nagi Yamazaki1
  • Akiko Kubo2
  • Saki Kamata3
  • Yuki Okuma3
  • Ting Yang1
  • Ayase Futatsugi1
  • Masaki Sakamoto1
  • Hirotsugu Hino1
  • Tadashi Ogawa4
  • Mamiko Fukuta4
5 more authors
  • Takashi Iwata5
  • Hiroshi Nishio5
  • Masaki Sugawara5
  • Kei Kawana3
  • Shuichi Hirai1
5 affiliations
  1. 1Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, 30-1 Ohyaguchi-Kami-Cho, Itabashi-ku, Tokyo 173-8610, Japan; (Y.F.); (N.Y.); (T.Y.); (A.F.); (M.S.); (H.H.); (S.H.)
  2. 2Division of Dermatology, , 7-5-1 Kusunoki-Cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan;
  3. 3Department of Obstetrics and Gynecology, , 30-1 Ohyaguchi-Kami-Cho, Itabashi-ku, Tokyo 173-8610, Japan; (S.K.); (Y.O.); (K.K.)
  4. 4Department of Legal Medicine, , 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan; (T.O.); (M.F.)
  5. 5Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan; (T.I.); (H.N.); (M.S.)
Read full textPDFCite

Related

  1. Clinicopathologic features and prognosis of human papillomavirus-negative cervical cancer: a single-center analysis of 33 cases
    Xinqiao Du, He Li, Guo Zhang
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. A Phase 1 Study of MK-1942, a Negative Allosteric Modulator of mGluR2, in Healthy Japanese to Flexibly Assess Factors Including CYP2C19 Phenotype.
    Chihiro Hasegawa, Yohei Doi, Tomona Hirano +10
    Clinical and translational sciencePeer-reviewedCC BY-NCFull textPharmacology & toxicologyEurope PMC
  3. Efficacy and Safety of Datopotamab Deruxtecan From a Single-Institution Experience in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody-Drug Conjugates.
    Hiroko Shimada, Maki Todo, Hiroshi Ishiguro +16
    Cancer medicinePeer-reviewedCC BY-NCFull textOncologyEurope PMC
  4. Case Report: Primary endometrioid adenocarcinoma of the cervix and secondary cervical involvement by endometrial carcinoma: diagnostic pitfalls and an integrated approach based on two cases
    Lina Geng, Tianci Fan, Guanwen Gao +2
    Frontiers in reproductive healthPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Diagnostic Accuracy of Multiparametric Ultrasound Versus Cross-Sectional Imaging for Differentiating Benign and Malignant Cervical Lymph Nodes: A Histopathology-Referenced Retrospective Study
    Inva Muçi, Steffen Dommerich, Philipp Arens +5
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{katoh2026serum,
  title = {{Serum Free Fatty Acid-Based Diagnostic Index for Cervical Cancer Including High-Risk HPV-Negative Cases: An Independent Validation Study}},
  author = {Yuki Katoh and Yosuke Fujii and Nagi Yamazaki and Akiko Kubo and Saki Kamata and Yuki Okuma and Ting Yang and Ayase Futatsugi and Masaki Sakamoto and Hirotsugu Hino and Tadashi Ogawa and Mamiko Fukuta and Takashi Iwata and Hiroshi Nishio and Masaki Sugawara and Kei Kawana and Shuichi Hirai},
  journal = {Diagnostics (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13703187},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Serum Free Fatty Acid-Based Diagnostic Index for Cervical Cancer Including High-Risk HPV-Negative Cases: An Independent Validation Study
AU  - Yuki Katoh
AU  - Yosuke Fujii
AU  - Nagi Yamazaki
AU  - Akiko Kubo
AU  - Saki Kamata
AU  - Yuki Okuma
AU  - Ting Yang
AU  - Ayase Futatsugi
AU  - Masaki Sakamoto
AU  - Hirotsugu Hino
AU  - Tadashi Ogawa
AU  - Mamiko Fukuta
AU  - Takashi Iwata
AU  - Hiroshi Nishio
AU  - Masaki Sugawara
AU  - Kei Kawana
AU  - Shuichi Hirai
PY  - 2026
DA  - 2026/10/01
JO  - Diagnostics (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13703187
SN  - 2075-4418
ER  -